Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
2.090
-0.050 (-2.34%)
Nov 19, 2025, 4:00 PM EST - Market closed
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $98.5 million as of November 20, 2025. Its market cap has increased by 104.16% in one year.
Market Cap
98.50M
Enterprise Value
-64.10M
1-Year Change
104.16%
Ranking
Category
Stock Price
$2.09
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $98.50M, a decrease of -81.79%. That is a compound annual growth rate of -33.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 98.50M | 26.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 926.57B |
| Johnson & Johnson | 480.15B |
| AbbVie | 415.07B |
| UnitedHealth Group | 281.84B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 238.00B |
| Abbott Laboratories | 226.19B |